TrialDiabetes, obesity & metabolism2025

Efficacy and safety of oral semaglutide in Chinese participants with type 2 diabetes: Subgroup analyses by baseline characteristics in the PIONEER 11 and 12 randomised controlled trials.

Linong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.